Implantable cardioverter defibrillators in paediatric patients: yet another example of healthcare divergence?
Jazyk angličtina Země Anglie, Velká Británie Médium print
Typ dokumentu úvodníky
PubMed
39228363
PubMed Central
PMC11403278
DOI
10.1093/europace/euae230
PII: 7748923
Knihovny.cz E-zdroje
- MeSH
- defibrilátory implantabilní * MeSH
- dítě MeSH
- elektrická defibrilace přístrojové vybavení MeSH
- lidé MeSH
- mladiství MeSH
- náhlá srdeční smrt prevence a kontrola MeSH
- věkové faktory MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- mladiství MeSH
- Publikační typ
- úvodníky MeSH
Zobrazit více v PubMed
Cacciola S. Team USA Says Air-Conditioners Are a ‘High-Performance Decision’—The New York Times. https://www.nytimes.com/2024/06/27/style/olympics-air-conditioners.html (27 June 2024).
Baskar S, Bao H, Minges KE, Spar DS, Czosek RJ. Characteristics and outcomes of pediatric patients who undergo placement of implantable cardioverter defibrillators: insights from the national cardiovascular data registry. Circ Arrhythm Electrophysiol 2018;11:e006542. PubMed
Suzuki T, Sumitomo N, Yoshimoto J, Miyazaki A, Hinokiyama K, Ushinohama Het al. Current trends in use of implantable cardioverter defibrillators and cardiac resynchronization therapy with a pacemaker or defibrillator in Japanese pediatric patients—results from a nationwide questionnaire survey. Circ J 2014;78:1710–6. PubMed
Balaji S, DiLorenzo MP, Fish FA, Etheridge SP, Aziz PF, Russell MWet al. Risk factors for lethal arrhythmic events in children and adolescents with hypertrophic cardiomyopathy and an implantable defibrillator: an international multicenter study. Heart Rhythm 2019;16:1462–467. PubMed
Nauffal V, Marstrand P, Han L, Parikh VN, Helms AS, Ingles Jet al. Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy. Eur Heart J 2021;42:3932–944. PubMed PMC
Carrick RT, De Marco C, Gasperetti A, Bosman LP, Gourraud JB, Trancuccio Aet al. Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe. Eur Heart J 2024;45:538–48. PubMed PMC
Winkel BG, Risgaard B, Sadjadieh G, Bundgaard H, Haunsø S, Tfelt-Hansen J. Sudden cardiac death in children (1–18 years): symptoms and causes of death in a nationwide setting. Eur Heart J 2014;35:868–75. PubMed
Chugh SS, Reinier K, Balaji S, Uy-Evanado A, Vickers C, Mariani Ret al. Population-based analysis of sudden death in children: the Oregon Sudden Unexpected Death Study. Heart Rhythm 2009;6:1618–622. PubMed PMC
Paul T, Krause U, Sanatani S, Etheridge SP. Advancing the science of management of arrhythmic disease in children and adult congenital heart disease patients within the last 25 years. Europace 2023;25:euad155. PubMed PMC
Thuraiaiyah J, Philbert BT, Jensen AS, Xing LY, Joergensen TH, Lim CWet al. Implantable cardioverter defibrillator therapy in paediatric patients for primary vs. secondary prevention. Europace 2024;26:euae245. PubMed PMC
